Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dysfunctional uterine bleeding (DUB)

C Bulletti1, C Flamigni, R A Prefetto

  • 1Department of Obstetrics and Gynecology, University of Bologna, Italy.

Annals of the New York Academy of Sciences
|September 30, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early application of percutaneous vertebroplasty reduces pain without affecting peripheral blood stem cell (PBSC) collection and transplant in newly diagnosed multiple myeloma (MM) patients.

European journal of cancer care·2013
Same author

Genomic DNA in human blastocoele fluid.

Reproductive biomedicine online·2013
Same author

Robotic radical parametrectomy with pelvic lymphadenectomy: our experience and review of the literature.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2012
Same author

Gynecological fertility-sparing surgery.

Placenta·2011
Same author

Ultrastructure of human mature oocytes after slow cooling cryopreservation with ethylene glycol.

Reproductive biomedicine online·2008
Same author

Permeability of human oocytes to ethylene glycol and their survival and spindle configurations after slow cooling cryopreservation.

Human reproduction (Oxford, England)·2007
Same journal

Multiomics Profiling During Autoimmune Demyelination Highlights a Complex Regulatory Role for Ataxin-1 in B Cells.

Annals of the New York Academy of Sciences·2026
Same journal

Global Trends in Light Pollution and Their Relationship With Socioeconomic Factors.

Annals of the New York Academy of Sciences·2026
Same journal

Wired for Corruption: Inter-Brain Synchrony Encodes Bribery-Related Value Information and Predicts Bribery Agreement.

Annals of the New York Academy of Sciences·2026
Same journal

LM-YOLO: A Lightweight Multi-Scale Enhanced Model for Forest Smoke Detection Using Unmanned Aerial Vehicles.

Annals of the New York Academy of Sciences·2026
Same journal

Polyrhythm Perception and Production: A Scoping Review.

Annals of the New York Academy of Sciences·2026
Same journal

DARTS-CNN-BiLSTM: Intelligent Fault Diagnosis for Computer Numerical Control Machine Tool Feed System.

Annals of the New York Academy of Sciences·2026
See all related articles

Abnormal uterine bleeding in perimenopausal women was effectively treated with gonadotropin-releasing hormone agonist (GnRHa) therapy combined with hormone replacement. This approach reduced bleeding and improved endometrial health, offering a medical alternative to surgery.

Area of Science:

  • Reproductive Endocrinology
  • Gynecology
  • Oncology

Background:

  • Irregular uterine bleeding is common in perimenopausal women, often linked to endometrial hyperplasia and hormonal imbalances.
  • This condition can lead to significant blood loss and increases the risk of endometrial cancer, frequently necessitating surgical intervention.
  • Current treatments often fail to address the underlying hormonal dysregulation and endometrial overstimulation.

Purpose of the Study:

  • To evaluate the efficacy of a novel therapeutic regimen for managing abnormal uterine bleeding and endometrial hyperplasia in perimenopausal women.
  • To assess the potential of this treatment to prevent endometrial cancer progression.
  • To provide a non-surgical alternative for patients with dysfunctional uterine bleeding (DUB).

Main Methods:

Related Experiment Videos

  • A cohort of 20 patients received depot gonadotropin-releasing hormone agonist (GnRHa) combined with transdermal 17-beta-estradiol and oral progestin.
  • This regimen aimed to induce controlled ovarian suppression while maintaining endometrial health.
  • Outcomes were compared against a control group of 20 patients.

Main Results:

  • The treatment group demonstrated a significant reduction in metrorrhagia (abnormal uterine bleeding).
  • Hemoglobin plasma concentration normalized, indicating improved management of blood loss.
  • Histological analysis confirmed adequate endometrial proliferation and secretory differentiation, with regression of endometrial hyperplasia observed.

Conclusions:

  • The combined GnRHa, estrogen, and progestin therapy is an effective medical treatment for abnormal uterine bleeding and endometrial hyperplasia in perimenopausal women.
  • This regimen offers a viable, non-surgical alternative to hysterectomy for DUB and may serve as a preventive measure against endometrial cancer.
  • The treatment successfully balances ovarian suppression with necessary hormonal support for endometrial health.